Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02748356 · ClinicalTrials.gov registry record · Phase 2
Impact of Probiotics on Urinary Symptoms in Spinal Cord Injury SCI and SB
A Phase 2 study, sponsored by Medstar Health Research Institute.
- Completed
- Registry status
- Phase 2
- Development phase
- 7
- Enrollment target
NCT02748356 is a Phase 2 study that has completed, run by Medstar Health Research Institute. The registered enrollment target is 7 participants.
The verdict
NCT02748356, a Phase 2 study, has completed, sponsored by Medstar Health Research Institute.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 7 participants
- Enrollment target
Study Summary
As a collaborative effort between MedStar National Rehabilitation Hospital (NRH), Children's National Medical Center (CNMC) Department of Urology, Children's Research Institute (CRI) Center for Genetic Medicine Research, Georgetown University, and MedStar Georgetown University Hospital, the overall objective of this study is to develop, validate, and assess a patient-initiated, probiotic-based, selfmanagement protocol that is initiated at the time of urinary symptoms. The self-management protocol will allow patients to manage urinary symptoms and avoid potentially unnecessary antibiotic use, and provide a readily-available means of maintaining health, function, and independence throughout the lifespan.
Interventions
- DRUG Lactobacillus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2016-01 |
| Est. Completion | 2018-12-31 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02748356
The ClinicalTrials.gov registry entry for NCT02748356 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medstar Health Research Institute, which has 115 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Lactobacillus is the first listed.
NCT02748356 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02748356 about?
NCT02748356 is a clinical study titled "Impact of Probiotics on Urinary Symptoms in Spinal Cord Injury SCI and SB". As a collaborative effort between MedStar National Rehabilitation Hospital (NRH), Children's National Medical Center (CNMC) Department of Urology, Children's Research Institute (CRI) Center for Genetic Medicine Research, Georgetown University, and MedStar Georgetown University Hospital, the overall ...
What is the current status of trial NCT02748356?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 7 participants. The study started on 2016-01. Estimated completion is 2018-12-31.
What interventions are being tested in trial NCT02748356?
The interventions under investigation include: Lactobacillus (DRUG).
Who is sponsoring clinical trial NCT02748356?
This trial is sponsored by Medstar Health Research Institute, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.